Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Phosphorylation of ATXN1 at Ser776 in the cerebellum.

Jorgensen ND, Andresen JM, Lagalwar S, Armstrong B, Stevens S, Byam CE, Duvick LA, Lai S, Jafar-Nejad P, Zoghbi HY, Clark HB, Orr HT.

J Neurochem. 2009 Jul;110(2):675-86. doi: 10.1111/j.1471-4159.2009.06164.x. Epub 2009 May 15.

2.

SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis.

Orr HT.

Prog Neurobiol. 2012 Dec;99(3):179-85. doi: 10.1016/j.pneurobio.2012.04.003. Epub 2012 Apr 16. Review.

3.

Progress in pathogenesis studies of spinocerebellar ataxia type 1.

Cummings CJ, Orr HT, Zoghbi HY.

Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1079-81. Review.

4.

Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1.

Ju H, Kokubu H, Lim J.

Mol Neurobiol. 2014 Dec;50(3):866-874. doi: 10.1007/s12035-014-8703-z. Epub 2014 Apr 22. Review.

5.

Regulation of ataxin-1 phosphorylation and its impact on biology.

Lagalwar S, Orr HT.

Methods Mol Biol. 2013;1010:201-9. doi: 10.1007/978-1-62703-411-1_13. Review.

PMID:
23754227
6.

Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1.

Zoghbi HY, Orr HT.

J Biol Chem. 2009 Mar 20;284(12):7425-9. doi: 10.1074/jbc.R800041200. Epub 2008 Oct 28. Review.

7.

Stabilization and Degradation Mechanisms of Cytoplasmic Ataxin-1.

Kohiyama MF, Lagalwar S.

J Exp Neurosci. 2016 May 5;9(Suppl 2):123-9. doi: 10.4137/JEN.S25469. eCollection 2015. Review.

8.
9.

Clinical, genetic, molecular, and pathophysiological insights into spinocerebellar ataxia type 1.

Matilla-DueƱas A, Goold R, Giunti P.

Cerebellum. 2008;7(2):106-14. doi: 10.1007/s12311-008-0009-0. Review.

PMID:
18418661

Supplemental Content

Support Center